Kevin D. Bunker - Net Worth and Insider Trading
Kevin D. Bunker Net Worth
The estimated net worth of Kevin D. Bunker is at least $12 Million dollars as of 2024-04-16. Kevin D. Bunker is the Chief Scientific Officer of Zentalis Pharmaceuticals Inc and owns about 874,439 shares of Zentalis Pharmaceuticals Inc (ZNTL) stock worth over $12 Million. Details can be seen in Kevin D. Bunker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kevin D. Bunker has not made any transactions after 2023-10-04 and currently still holds the listed stock(s).
Transaction Summary of Kevin D. Bunker
Kevin D. Bunker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kevin D. Bunker owns 1 companies in total, including Zentalis Pharmaceuticals Inc () .
Click here to see the complete history of Kevin D. Bunker’s form 4 insider trades.
Insider Ownership Summary of Kevin D. Bunker
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| Zentalis Pharmaceuticals Inc | 2023-10-04 | Chief Operating Officer |
Kevin D. Bunker Latest Holdings Summary
Kevin D. Bunker currently owns a total of 1 stock. Kevin D. Bunker owns 874,439 shares of Zentalis Pharmaceuticals Inc (ZNTL) as of October 4, 2023, with a value of $12 Million.
Latest Holdings of Kevin D. Bunker
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals Inc | 2023-10-04 | 874,439 | 13.28 | 11,612,550 |
Holding Weightings of Kevin D. Bunker
Kevin D. Bunker Form 4 Trading Tracker
According to the SEC Form 4 filings, Kevin D. Bunker has made a total of 35 transactions in Zentalis Pharmaceuticals Inc (ZNTL) over the past 5 years, including 1 buys and 34 sells. The most-recent trade in Zentalis Pharmaceuticals Inc is the sale of 6,068 shares on October 4, 2023, which brought Kevin D. Bunker around $118,326.
Insider Trading History of Kevin D. Bunker
- 1
Kevin D. Bunker Trading Performance
GuruFocus tracks the stock performance after each of Kevin D. Bunker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kevin D. Bunker is 79.58%. GuruFocus also compares Kevin D. Bunker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kevin D. Bunker within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kevin D. Bunker's insider trading performs compared to the benchmark.
Performance of Kevin D. Bunker
Average Relative Return
72.93%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Relative Return(%) | 34.44 | 79.58 | 49.31 | 72.93 | 42.96 | -8.88 |
| Relative Return to S&P 500(%) | 26.1 | 61.31 | 20.73 | 19.51 | 12.88 | -24.46 |
Kevin D. Bunker Ownership Network
Ownership Network List of Kevin D. Bunker
Ownership Network Relation of Kevin D. Bunker
Kevin D. Bunker Owned Company Details
What does Zentalis Pharmaceuticals Inc do?
Who are the key executives at Zentalis Pharmaceuticals Inc?
Kevin D. Bunker is the Chief Operating Officer of Zentalis Pharmaceuticals Inc. Other key executives at Zentalis Pharmaceuticals Inc include Chief Financial Officer Melissa B, Epperly , General Counsel Andrea Paul , and Chief Medical Officer Carrie Brownstein .
Zentalis Pharmaceuticals Inc () Insider Trades Summary
Over the past 18 months, Kevin D. Bunker made 3 insider transaction in Zentalis Pharmaceuticals Inc () with a net sale of 96,375. Other recent insider transactions involving Zentalis Pharmaceuticals Inc () include a net sale of 132,200 shares made by Cam Gallagher , a net sale of 24,575 shares made by Melissa B, Epperly , and a net purchase of 17,000 shares made by David Michael Johnson .
In summary, during the past 3 months, insiders sold 28,862 shares of Zentalis Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 28,862 shares. During the past 18 months, 273,673 shares of Zentalis Pharmaceuticals Inc () were sold and 22,000 shares were bought by its insiders, resulting in a net sale of 251,673 shares.
Zentalis Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Zentalis Pharmaceuticals Inc Insider Transactions
Kevin D. Bunker Mailing Address
Above is the net worth, insider trading, and ownership report for Kevin D. Bunker. You might contact Kevin D. Bunker via mailing address: C/o Zentalis Pharmaceuticals, Inc., 530 Seventh Avenue, Suite 2201, New York Ny 10018.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
